1. Institute for Risk Assessment Sciences, Division Environmental Epidemiology, Utrecht University, Utrecht, The Netherlands;
2. Zanjan University of Medical Sciences, Zanjan, Iran;
3. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD;
4. Department of Neurology and Vascular and Genomic Center, Changhua Christian Hospital, Changhua, Taiwan;
5. Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan;
6. Laboratory of Mitochondrial Medicine, Chunghua Christian Hospital, Taipei, Taiwan;
7. Centre of Chronic Immunodeficiency, University Medical Centre Freiburg, Freiburg, Germany;
8. Danish Cancer Society Research Center, Copenhagen, Denmark;
9. Genomic Epidemiology Group, German Cancer Research Center, Heidelberg, Germany;
10. Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbrücke, Nuthetal, Germany;
11. Hellenic Health Foundation, Athens, Greece;
12. WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece;
13. Department of Epidemiology, Harvard School of Public Health, Boston, MA;
14. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece;
15. Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;
16. Cancer Registry and Histopathology Unit, “Civic - M.P. Arezzo” Hospital, ASP Ragusa, Italy;
17. Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy;
18. Molecular and Nutritional Epidemiology Unit, ISPO Cancer Research and Prevention Institute, Florence, Italy;
19. Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway;
20. Department of Research, Cancer Registry of Norway, Oslo, Norway;
21. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;
22. Samfundet Folkhälsan, Helsinki, Finland;
23. Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain;
24. CIBER Epidemiology and Public Health CIBERESP, Spain;
25. Navarre Public Health Institute, Pamplona, Spain;
26. Translational Research Laboratory and Unit of Nutrition, Environment and Cancer Research Program in Cancer Epidemiology, Catalan Institute of Oncology, Biomedical Research Institute (IDIBELL), Barcelona, Spain;
27. Public Health Direction and Biodonostia Research Institute Ciberesp, Basque Regional Health Department, Vitoria, Spain;
28. Public Health Directorate, Asturias, Spain;
29. Andalusian School of Public Health, Granada, Spain;
30. Instituto de Investigación Biosanitario de Granada, Granada, Spain;
31. Department of Radiation Sciences, Oncology Umeå University, Umeå, Sweden;
32. Department of Laboratory Medicine, Clinical Chemistry, Lund University, Malmö, Sweden;
33. Skåne University Hospital, Malmö, Sweden;
34. Division of Oncology, Department of Clinical Sciences, Lund University, Malmö, Sweden;
35. Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht;
36. National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands;
37. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands;
38. The School of Public Health, Imperial College London, London, United Kingdom;
39. MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, United Kingdom;
40. School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom;
41. Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom;
42. Genetics Section, International Agency for Research on Cancer, Lyon, France;
43. Department of Genomics of Common Disease, School of Public Health, Imperial College London, London, United Kingdom;
44. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; and
45. Human Genetics Foundation, Turin, Italy